Josh Marshall

 Have a tip? Send it Here!
Josh Marshall is the founder and Editor-in-Chief of TPM.

The NIH Funds-Ghosting, A Follow Up Report Prime Badge
 Member Newsletter

Two days ago, I wrote about a pattern operating largely under the radar in the President’s war against higher education. We know about the general grant freezes on about half a dozen elite universities. Then there are countless other grant terminations across a much larger group of universities. One of the complexities of this story is that there are so many different versions of cancellations and terminations going on, it’s hard to figure out which is which. It’s just as hard deciphering to what extent the differences even matter. There are ones tied to prohibited words and concepts (DEI, transgender); there are ones tied to targeted universities; others are terminated on generic efficiency grounds; others are canceled for no clear reason. Are these categories even meaningful or is that all just more smoke and mirrors and distraction?

Read More 
Very Interesting Follow Up About that OPM Contract

From an anonymous TPM Reader …

As a former OPM appointee, this seems suspect for numerous reasons. Going through the Federal News Network article, the first thing that doesn’t make sense is in the second paragraph. Leading with retirement applications and RIFs is really odd, since the federal retirement process is a government-wide problem that a central OPM system isn’t going to fix alone, and OPM has no real role in RIFs for other agencies. The small price tag you cite is another huge red flag. This must be for OPM systems only (internal, not in a government-wide capacity) and I know from experience working with Workday and companies like them that $300K doesn’t go very far. I think they got rid of too many people at OPM too quickly (a mix of policy expert people and hands on execution people) and this is a desperate effort to fill that gap.

Read More 
Elon’s OPM Hands Out No Bid Contract to Cloud-Based AI HR Company Prime Badge

After firing much of its staff, the Office of Personal Management, under Elon Musk’s effective control since late January, has handed out a no bid contract to cloud-AI-based HR company Workday to help handle the mountain of terminations, retirements and layoffs built up over the first three months of the Trump administration. OPM stated in justification for the sole-source, no-bid contract that “an urgent confluence of operational failures and binding federal mandates that require immediate action.”

Read More 
Sic Transit, DeTransitioning Edition

I am reading an April 21, 2025 letter from Acting Assistant Secretary of Defense for Health Affairs Dr. Stephen Ferrara which provides guidance for discontinuing treatment of minors with gender dysphoria at military medical treatment facilities. After noting the Pentagon policy banning the initiation or continuation of treatment with puberty blockers or cross-sex hormone therapy, the letter allows clinicians to offer a tapering-off regime which can last between 6 and 12 weeks, during which military doctors can write prescriptions. Anything longer than 12 weeks must get express approval from Ferrara’s office. The letter also notes administrative changes which will require patients to fill tapering prescriptions “at private sector pharmacies at their own expense.”

Outgoing UMich Prez Santa Ono Pulls His Name from Academic Freedom Letter

Over the weekend, University of Michigan President Santa Ono announced that he was leaving his post to take up the leadership of the University of Florida. It was an interesting choice. It’s been reported that Ono had been warier of resisting or challenging the dictates of the Trump administration than the majority of the University’s Board of Regents, the members of which are elected in statewide elections. The majority of appointees to the University of Florida’s board are appointed by the state’s governor, Ron DeSantis.

Read More 
Let’s Remember Why There’s a System of Federal Research Grants to Universities

This is largely preaching to the choir, but it’s absent enough from the news coverage that is worth stating clearly. Most right-thinking people are aghast at Trump’s onslaught on higher education. The range of reasons is endlessly discussed and doesn’t need to be enumerated here. But through those discussions is the subtext that higher education is dependent on federal subsidies. There is some truth to this when it comes to Pell grants and backstopping student loans. But with grants to fund scientific research, it turns the reality on its head. It’s the federal government which is the initiator here, both historically and also in terms of the ongoing dynamic of grant-making.

Read More 
Why Do They Have It In For Biomedical Research? Prime Badge
 Member Newsletter

Here is a brief follow-up on the question TPM Reader MA addresses in an earlier post: why does the Trump administration have it in for biomedical/disease research? It’s a really good question and one I have not seen an adequate explanation for. But having been reporting on this for a few months now I think I do get the outlines of it.

Read More 
Self-Destruction

A note from TPM Reader MA on biomedical research. I’m sharing it because it’s a good simple explanation not only of the nuts and bolts reality of “your cure isn’t going to be there when you need it” but the massive hit to global competitiveness and economic advantage …

I’m racking my brain trying to figure out why Trump would want to kill funding for curing cancer/Alzheimer’s etc. I guess, as is often the case, with Trump, the simple explanation is the most likely. He sees the university as the enemy and wants to use whatever federal leverage he can to attack them, even if it ends up destroying one of the areas in which the US has a huge comparative advantage. There are significant economic consequences to spiking medical research in the universities: this subsidizes the training of people who will work in the industry, and it drives the types of blue sky research that industry doesn’t want to do, but that it benefits greatly from. It creates a vacuum that other countries will rush to fill. If it persists, the comparative advantage that the US has gained by attracting top global talent will collapse.

Read More 
Conspiracy of Silence: How Trump is Covertly Strangling Billions in Disease Cure Research Prime Badge
 Member Newsletter

The following is very important news about the Trump White House’s unfolding war against biomedical/disease-cure research in the United States. But the set up is a bit complicated. So I want to note both the complexity and the importance in advance, because I want to really encourage you to read the set up and the details. It’s important stuff and most of it remains unknown to the public, though a few threads of the story have been published.

Back in late March and early April, the Trump administration announced grant freezes against a series of elite private universities, all notionally tied to charges of lax vigilance against antisemitism. The targeted universities eventually included Brown, Columbia, Harvard, University of Pennsylvania, Princeton, Cornell and Northwestern. Harvard eventually sued the administration. Princeton has decided to fight the cuts but hasn’t sued. But most of the universities have generally kept quiet about what they’re doing. And in most cases what that means is that they’re negotiating with the administration and trying to keep their faculties quiet to avoid antagonizing anyone during those notional negotiations.

Read More 
So This Happened

Donald Trump’s Truth Social recently started a streaming service for MAGAs and “pro-family” Christians called Truth+. Hunter Walker was surprised to find that among the top ten most watched movies featured for viewers was a “documentary” about how alien lizard people secretly rule the earth. And that was only the beginning of the fun.

Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Deputy Editor:
Editor-at-Large:
Contributing Editor:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher & Digital Producer:
Senior Developer:
Senior Designer:
OSZAR »